Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -51.06% is 46% above its 5-year average of -94.86%, near the high end of its 5-year range (-220.77%–-27.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.76% above its 12-month average of -59.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -51.06%.
RETURN ON INVESTED CAPITAL (ROIC)
-51.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-59.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-89.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-94.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.76%
CURRENT VS 3Y AVG
+42.77%
CURRENT VS 5Y AVG
+46.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 669 covered companies
CURRENT VS SECTOR MEDIAN
-52.43%
vs the sector median at left
Immunome, Inc.
Market Cap
$1.97B
Return on Invested Capital (ROIC)
-51.06%
TTM Avg
-59.21%
3Y Avg
-89.23%
5Y Avg
-94.86%
Market Cap
$1.96B
Return on Invested Capital (ROIC)
-4.68%
TTM Avg
-2.93%
3Y Avg
-9.02%
5Y Avg
-10.48%
Market Cap
$1.95B
Return on Invested Capital (ROIC)
-6.53%
TTM Avg
-15.76%
3Y Avg
-21.33%
5Y Avg
-21.68%
Market Cap
$2.00B
Return on Invested Capital (ROIC)
6.33%
TTM Avg
5.44%
3Y Avg
-1.33%
5Y Avg
-7.01%
Market Cap
$2.03B
Return on Invested Capital (ROIC)
21.77%
TTM Avg
7.57%
3Y Avg
-7.64%
5Y Avg
-15.11%
Market Cap
$2.03B
Return on Invested Capital (ROIC)
-57.17%
TTM Avg
-63.49%
3Y Avg
-47.92%
5Y Avg
-137.67%
Market Cap
$2.03B
Return on Invested Capital (ROIC)
15.47%
TTM Avg
9.87%
3Y Avg
8.85%
5Y Avg
8.76%
Market Cap
$1.90B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-32.05%
3Y Avg
-35.56%
5Y Avg
-35.59%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-1.08%
3Y Avg
-2.19%
5Y Avg
-2.71%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.97B | -51.06% | -59.21% | -89.23% | -94.86% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -4.68% | -2.93% | -9.02% | -10.48% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -6.53% | -15.76% | -21.33% | -21.68% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 6.33% | 5.44% | -1.33% | -7.01% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 21.77% | 7.57% | -7.64% | -15.11% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.03B | -57.17% | -63.49% | -47.92% | -137.67% |
| Progyny, Inc. (PGNY)vs › | $2.03B | 15.47% | 9.87% | 8.85% | 8.76% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -44.21% | -32.05% | -35.56% | -35.59% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 1.72% | -1.08% | -2.19% | -2.71% |
| Alvotech (ALVO)vs › | $2.06B | 3.61% | 5.05% | -22.39% | -28.34% |
ROIC
-51.1%
ROE
-48.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -51.06% |
| 2026-03-31 | -40.31% |
| 2025-12-31 | -35.12% |
| 2025-09-30 | -87.42% |
| 2025-06-30 | -82.15% |
| 2025-03-31 | -69.94% |
| 2024-12-31 | -164.47% |
| 2024-09-30 | -146.06% |
| 2024-06-30 | -105.96% |
| 2024-03-31 | -82.13% |
| 2023-12-31 | -86.44% |
| 2023-09-30 | -32.35% |
| 2023-06-30 | -176.59% |
| 2023-03-31 | -127.64% |
| 2022-12-31 | -220.77% |
| 2022-09-30 | -159.46% |
| 2022-06-30 | -118.90% |
| 2022-03-31 | -86.69% |
| 2021-12-31 | -52.29% |
| 2021-09-30 | -39.10% |
| 2021-06-30 | -27.25% |
| 2021-03-31 | -35.10% |
| 2020-12-31 | -29.22% |
| 2020-09-30 | -157.64% |
| 2020-06-30 | -111.85% |
| 2019-12-31 | -286.89% |
